Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Nonprescription Medicines Association Releases 2008 OTC Sales Ranking List

This article was originally published in PharmAsia News

Executive Summary

At the recent China Self-Medication Annual Meeting, China's Nonprescription Medicines Association released its annual statistics and survey results of the local OTC businesses. Xiuzheng Pharmaceutical Group, Xian-Janssen, Harbin Pharmaceutical Group, Sanjiu Medical & Pharmaceutical and TSKF are listed as the five companies with biggest sales in 2008. For OTC chemical drugs, TSKF's Fenbid, Bayer's Saridon, Shanghai Johnson & Johnson's Motrin and Tylenol, and HPG's Anruike garnered the top spots. TSKF's new Contac and Bayer's White & Black were among the top five for cold and cough; Wyeth's Caltrate D and Bayer'sRedoxon for vitamins and minerals; Xian-Janssen's Motilium and Bayer's Talcid for digestives; and Xian-Janssen's Daktarin and Pevisone for external use agents. Local products dominated in patent TCM, surgery and women's health sectors. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel